As of Oct 21
| +0.14 / +4.65%|
The 3 analysts offering 12-month price forecasts for Intellipharmaceutics International Inc have a median target of 6.04, with a high estimate of 8.00 and a low estimate of 6.00. The median estimate represents a +91.72% increase from the last price of 3.15.
The current consensus among 3 polled investment analysts is to Buy stock in Intellipharmaceutics International Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.